Related references
Note: Only part of the references are listed.
Review
Oncology
Florian J. Groelly et al.
Summary: Cells have a complex network called the DNA damage response (DDR) to prevent detrimental mutations and coordinate DNA repair, cell-cycle checkpoint activation, and other cellular responses. Mutations in DDR genes are frequently found in cancer, causing genomic instability and influencing the tumor's response to DNA damage treatments. Tumors with mutated BRCA1 or BRCA2 are particularly susceptible to chemotherapeutic inhibitors of PARP, which has become a targeted therapy for cancer.
NATURE REVIEWS CANCER
(2023)
Article
Oncology
Rebecca L. Siegel et al.
Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.
CA-A CANCER JOURNAL FOR CLINICIANS
(2022)
Review
Oncology
Antonella Padella et al.
Summary: Members of the Poly(ADP-ribose) polymerase (PARP) superfamily play crucial roles in various biological processes, particularly in the DNA damage response (DDR). PARP1, PARP2, and PARP3 serve as sensors for DNA damage, activating different intracellular repair pathways. This review provides an overview of the functional role of PARPs in DDR pathways and their relationship with cell cycle phases. Furthermore, PARP inhibitors have shown potential therapeutic activity in acute leukemia, encouraging the development of clinical trials.
JOURNAL OF HEMATOLOGY & ONCOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Zehao Wang et al.
Summary: This study revealed that circROBO1 is upregulated in breast cancer liver metastasis and is associated with poor prognosis. CircROBO1 facilitates the carcinogenesis and liver metastasis of breast cancer through the circROBO1/KLF5/FUS feedback loop, which inhibits the selective autophagy of afadin by suppressing the transcription of BECN1.
Article
Biochemistry & Molecular Biology
Chonghui Hu et al.
Summary: This study found that the CAF-specific circRNA circFARP1 plays a critical role in pancreatic ductal adenocarcinoma (PDAC), and is associated with gemcitabine resistance and poor patient survival. Mechanistically, circFARP1 regulates the interaction between CAV1, ZNRF1, and LIF, influencing the development of tumor cell stemness and drug resistance. Additionally, high levels of circFARP1 are associated with elevated serum LIF levels and poor patient survival in PDAC.
Review
Oncology
Lasse S. Kristensen et al.
Summary: Circular RNAs (circRNAs) are a novel class of primarily non-coding RNAs with increasingly recognized roles in cancer development and progression through diverse mechanisms of action. In this review, the authors summarize the current understanding of circRNA biogenesis, regulation, physiological functions and pathophysiological roles in cancer. They also discuss the clinical potential of circRNAs as biomarkers, therapeutic agents and drug targets in oncology, as well as the research controversies, technical issues, and biological knowledge gaps that need to be addressed.
NATURE REVIEWS CLINICAL ONCOLOGY
(2022)
Review
Gastroenterology & Hepatology
Laura D. Wood et al.
Summary: This review discusses the pathogenesis, early detection methods, and treatment considerations of pancreatic ductal adenocarcinoma (PDAC). Recent advances in understanding PDAC have led to significant improvements in detection and treatment, but coordinated efforts are needed to maximize clinical impact for patients and overall survival.
Article
Biotechnology & Applied Microbiology
Qin Yuan et al.
Summary: This study analyzed tissue data from pulmonary TB patients and identified several key genes and constructed an interaction network related to the development of pulmonary TB. A high accuracy model was constructed using machine learning and single-factor analysis. These findings may contribute to the early diagnosis and treatment of pulmonary TB.
BIOMED RESEARCH INTERNATIONAL
(2022)
Article
Biochemistry & Molecular Biology
Yong Xi et al.
Summary: This study found that circBCAR3 is highly expressed in esophageal cancer and it can promote the tumorigenesis of esophageal cancer by interacting with miR-27a-3p to upregulate TNPO1. The splicing factor QKI was identified as a positive regulator of circBCAR3 and hypoxia upregulates E2F7 to transcriptionally activate QKI.
Article
Multidisciplinary Sciences
Jianfang Li et al.
Summary: In this study, the authors demonstrate that TET1 plays a crucial role in the generation of functional insulin-producing cells. They find that FOXA2 physically interacts with TET1 and contributes to the specific recruitment of TET1 to the regulatory elements of pancreatic lineage determinants, mediating chromatin opening.
NATURE COMMUNICATIONS
(2022)
Article
Genetics & Heredity
Shuang Deng et al.
Summary: This study reveals that METTL3-mediated RNA N-6-methyladenosine (m(6)A) deposition leads to DNA demethylation. The m(6)A reader protein FXR1 recruits DNA 5-methylcytosine dioxygenase TET1 to chromatin, which is linked to chromatin accessibility and gene transcription.
Article
Cell Biology
Kun Cai et al.
Summary: FOXD1 overexpression in pancreatic cancer is associated with adverse prognostic index and enhances aerobic glycolysis, proliferation, invasion, and metastasis of cancer cells.
CELL DEATH & DISEASE
(2022)
Article
Gastroenterology & Hepatology
Stephan B. Dreyer et al.
Summary: DDR deficiency and replication stress are independent of each other, offering opportunities for therapy in DDR-proficient PC and after platinum therapy. Patient-derived cell lines faithfully recapitulate the epithelial component of pancreatic tumors, including previously described molecular subtypes, and serve as a valuable model for studying novel therapeutic strategies targeting DDR and replication stress in PC.
Article
Gastroenterology & Hepatology
Lukas Perkhofer et al.
Summary: Complex rearrangement patterns and mitotic errors are characteristics of most PDAC, caused by DNA double-strand breaks and defective DNA repair pathways. DSB repair pathways, such as HR, play a crucial role in maintaining genomic integrity, and deficiencies in DDR pathways like BRCA1 and BRCA2 are common in both inherited and sporadic PDAC, leading to potential vulnerabilities to new therapeutic interventions. The POLO trial with olaparib showed promising results in PDAC patients with germline BRCA1/2 mutations, suggesting a potential for improved outcomes in this subgroup.
Review
Cell Biology
Mona Teng et al.
Summary: Prostate cancer, the most commonly diagnosed non-cutaneous cancer in North American men, is often treated with androgen deprivation therapy. However, resistance can develop, leading to lethal disease. FOXA1, a pioneer factor that helps shape and regulate androgen receptor signaling, plays a crucial role in prostate cancer development and progression. Mutations in FOXA1 can result in functional alterations, and post-translational modifications can also modulate its activity in prostate cancer. Identifying the function and regulation of FOXA1 in prostate cancer is important for guiding future clinical interventions.
Article
Oncology
Xuehui Wang et al.
Summary: Hsa_circ_0005273 is overexpressed in breast cancer tissues and cell lines, promoting BC progression by regulating the miR-200a-3p/YAP1 axis and inactivating the Hippo signaling pathway.
Depletion of hsa_circ_0005273 inhibits tumor cell proliferation, migration, and cell cycle progression, suggesting it as a potential therapeutic target for breast cancer.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
(2021)
Article
Biochemistry & Molecular Biology
Peng Shen et al.
Summary: The study identified that circNEIL3 is upregulated in PDAC and promotes tumor growth and metastasis by regulating the expression of ADAR1 through sponging miR-432-5p, ultimately affecting cell cycle progression and promoting EMT. The circNEIL3/miR-432-5p/ADAR1/GLI1/cell cycle and EMT axis is correlated with the clinical stage and overall survival of PDAC patients.
Review
Oncology
Sara De Dosso et al.
Summary: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a poor prognosis. Early diagnosis is challenging due to lack of symptoms, and treatment options include FOLFIRINOX and gemcitabine plus nab-paclitaxel depending on patient characteristics. The lack of molecular and genetic biomarkers hinders optimal patient stratification and treatment decisions, highlighting the need for further research on predictive and prognostic biomarkers and novel treatment strategies to improve outcomes for metastatic pancreatic cancer patients.
CANCER TREATMENT REVIEWS
(2021)
Article
Oncology
Xiaoxiao Zhou et al.
Summary: The study revealed that circ-MBOAT2 regulates the development of pancreatic cancer and glutamine metabolism through the miR-433-3p/GOT1 axis, suggesting a potential therapeutic target for inhibiting tumor formation.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
(2021)
Review
Oncology
Wenzheng Liu et al.
Summary: TET1 is a crucial demethylation protein, playing important roles in maintaining genomic methylation homeostasis and pluripotency of stem cells. Its functions in different tumors are still under investigation.
BIOMARKER RESEARCH
(2021)
Article
Oncology
Chaofan Peng et al.
Summary: The study identified a novel circRNA, circ-GALNT16, which was downregulated in colorectal cancer (CRC) and negatively correlated with poor prognosis. Circ-GALNT16 suppressed CRC progression by inhibiting Serpine1 expression through regulating the sequence-specific DNA binding ability of the hnRNPK-p53 transcriptional complex. This circRNA may serve as a potential biomarker and therapeutic target for CRC.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
(2021)
Article
Endocrinology & Metabolism
Tamara Casteels et al.
Summary: Loss of FoxO1 signaling in response to metabolic stress contributes to type II diabetes by inducing dedifferentiation of pancreatic beta cells. Pharmacological inhibition of FoxO1 can model beta-cell dedifferentiation by downregulating beta-cell-specific transcription factors and aberrantly expressing progenitor genes and alpha-cell markers. Screening identified loperamide as a small molecule that can prevent FoxO inhibitor-induced glucagon expression and enhance insulin secretion by modulating calcium levels, intracellular pH, and FoxO1 localization.
MOLECULAR METABOLISM
(2021)
Review
Biochemical Research Methods
Liang Chen et al.
Summary: Circular RNAs (circRNAs) are a unique class of RNA molecules produced by back-splicing of linear RNA, and recent advances in sequencing technologies and bioinformatics tools have greatly expanded our understanding of their biological functions and practical applications. There are now numerous bioinformatics tools available for circRNA annotation, identification, and network analysis, which continue to evolve to support various research projects in this field.
BRIEFINGS IN BIOINFORMATICS
(2021)
Article
Medicine, Research & Experimental
Reem Ali et al.
Summary: The study found that overexpression of LIG1 and LIG3 is associated with aggressive phenotypes, platinum resistance, and poor progression-free survival in ovarian cancer, while deficiency of LIG4 is linked to platinum resistance and worse outcomes. Depletion of LIG1 can increase platinum cytotoxicity in ovarian cancer cells. These findings suggest that LIG1 may be an attractive target for personalizing ovarian cancer therapy.
Article
Biochemistry & Molecular Biology
Hao Li et al.
Review
Genetics & Heredity
Annahita Sallmyr et al.
Article
Biochemistry & Molecular Biology
Xiaolong Xu et al.
Article
Oncology
Zhenwei He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
(2019)
Article
Gastroenterology & Hepatology
Tingting Wang et al.
JOURNAL OF GASTROENTEROLOGY
(2019)
Review
Biochemistry & Molecular Biology
Ashis K. Basu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2018)
Editorial Material
Medicine, General & Internal
Hedy L. Kindler
NEW ENGLAND JOURNAL OF MEDICINE
(2018)
Review
Environmental Sciences
Nimrat Chatterjee et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
(2017)
Article
Cell Biology
Liang Shi et al.
CELL DEATH & DISEASE
(2017)
Review
Biochemistry & Molecular Biology
Anthony Tubbs et al.
Review
Cell Biology
Ling-Ling Chen
NATURE REVIEWS MOLECULAR CELL BIOLOGY
(2016)
Review
Pathology
Morgane Macheret et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10
(2015)
Article
Biochemistry & Molecular Biology
Simon J. Conn et al.
Article
Multidisciplinary Sciences
Svetlana V. Khoronenkova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2015)
Article
Biochemistry & Molecular Biology
Reut Ashwal-Fluss et al.
Review
Neurosciences
Lisa D. Moore et al.
NEUROPSYCHOPHARMACOLOGY
(2013)
Review
Multidisciplinary Sciences
Stephen P. Jackson et al.
